Found 9 matching trials
A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma PHASE4 This Phase IV study is an a multi-centre, randomised open label, two way cr...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Reversal of Acute β-Blocker Induced Bronchoconstriction PHASE4 Current therapies for the management of asthma include inhalers. Types of t...
Show More Location
Asthma and Allergy Research Group, Unviersity of Dundee
Learn More & Join Trial
Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy Subjects PHASE4 Contextualization: Exercise is a common triggers of bronchospasm in patient...
Show More Location
Jaqueline Ribas de Melo
Learn More & Join Trial
A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This is a phase IIIa, randomised, double-blind, double-dummy, parallel grou...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial PHASE4 A randomised controlled trial to test the hypothesis that inhaled therapies...
Show More Learn More & Join Trial
Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD PHASE2 The purpose of this study is to determine whether the Aridol (mannitol) cha...
Show More Location
Respiratory Clinic
Learn More & Join Trial
Cardiovascular Consequences of Inhaled Short-acting Beta-agonist Use PHASE1 The goal of this clinical trial is to test the impact inhalers have on bloo...
Show More Location
Clinical Physiology Laboratory
Learn More & Join Trial
Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients PHASE2 In order to obtain information on a wider range of doses of GW642444 (a pos...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 This study is primarily designed to assess the dose response, dose interval...
Show More Location
GSK Investigational Site
Learn More & Join Trial